Fennec Pharmaceuticals Inc (FENC)

6.50 -0.08  -1.22% NASDAQ Jul 26, 16:58 USD
View Full Chart
Price Chart
View All FENC News

News

View All Events

Events

Date Type Description
08/05/2021 Earnings Results Q2 2021 Earnings Results
05/13/2021 Earnings Results Q1 2021 Earnings Results
03/30/2021 Earnings Results Q4 2020 Earnings Results
11/16/2020 Earnings Results Q3 2020 Earnings Results
08/05/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children.
  • URL: https://www.fennecpharma.com
  • Investor Relations URL: http://fennecpharma.com/investors/company-profile/
  • HQ State/Province: North Carolina
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 05, 2021
  • Last Earnings Release: May. 13, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.